Archive readyExternal timestamp ready

株式会社メディネット | 株主・投資家情報 | 経営方針

https://www.medinet-inc.co.jp/ir/managementpolicy/policy.php

April 20, 2026 at 06:04 PM JST•The archive page, viewer, and downloads use this saved version.

April 20, 2026 at 06:04 PM JST·www.medinet-inc.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

External timestamp

The evidence pack includes the third-party timestamp files.

External timestamp

External timestamp ready

Provider

DigiCert RFC3161

TSA time

April 21, 2026 at 02:21 AM JST

Saved page

株式会社メディネット | 株主・投資家情報 | 経営方針

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.medinet-inc.co.jp/ir/managementpolicy/policy.php

StartedApril 20, 2026 at 06:04 PM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page outlines Medinet's management policy and strategy. Founded in 1999, the company processes cells for immunotherapy and operates the Shinagawa CPF facility near Haneda Airport. The facility holds permits for manufacturing specified cell-processed products and regenerative medicine products. Medinet aims to leverage its strengths and expand into new business areas including cell processing for companies and CDMO services. The company targets early profitability and accelerated growth through regenerative medicine product development. Long-term, it pursues "VISION2030," aiming to become a Healthcare Innovating Company contributing to a Well-Being society through health improvement and disease treatment.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.